These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 6756514)
1. Autologous bone marrow transplantation in metastatic breast cancer. Stewart PS Breast Cancer Res Treat; 1982; 2(1):85-92. PubMed ID: 6756514 [TBL] [Abstract][Full Text] [Related]
2. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108 [TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for metastatic breast cancer. Saez RA; Selby GB; Slease RB; Epstein RB; Mandanas RA; Confer DL J Okla State Med Assoc; 1994 Sep; 87(9):405-10. PubMed ID: 7996314 [TBL] [Abstract][Full Text] [Related]
4. The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer. Hortobagyi GN Bone Marrow Transplant; 1988 Nov; 3(6):525-30. PubMed ID: 3063320 [TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation. Ghalie R; Richman CM; Adler SS; Cobleigh MA; Korenblit AD; Manson SD; McLeod BC; Taylor SG; Valentino LA; Wolter J J Clin Oncol; 1994 Feb; 12(2):342-6. PubMed ID: 8113841 [TBL] [Abstract][Full Text] [Related]
6. Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy. Shah AB; Hartsell WF; Ghalie R; Kaizer H Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1433-8. PubMed ID: 7635784 [TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer. Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837 [TBL] [Abstract][Full Text] [Related]
8. Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. Antman K; Gale RP Ann Intern Med; 1988 Apr; 108(4):570-4. PubMed ID: 3279894 [TBL] [Abstract][Full Text] [Related]
9. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. Shpall EJ; Jones RB; Bast RC; Rosner GL; Vandermark R; Ross M; Affronti ML; Johnston C; Eggleston S; Tepperburg M J Clin Oncol; 1991 Jan; 9(1):85-93. PubMed ID: 1985173 [TBL] [Abstract][Full Text] [Related]
10. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team. Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Nagasawa S Cancer; 1994 Mar; 73(6):1678-85. PubMed ID: 7512436 [TBL] [Abstract][Full Text] [Related]
11. Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue. Spitzer TR; Cirenza E; McAfee S; Foelber R; Zarzin J; Cahill R; Mazumder A Bone Marrow Transplant; 1995 Apr; 15(4):537-42. PubMed ID: 7655378 [TBL] [Abstract][Full Text] [Related]
12. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. Rowlings PA; Williams SF; Antman KH; Fields KK; Fay JW; Reed E; Pelz CJ; Klein JP; Sobocinski KA; Kennedy MJ; Freytes CO; McCarthy PL; Herzig RH; Stadtmauer EA; Lazarus HM; Pecora AL; Bitran JD; Wolff SN; Gale RP; Armitage JO; Vaughan WP; Spitzer G; Horowitz MM JAMA; 1999 Oct; 282(14):1335-43. PubMed ID: 10527180 [TBL] [Abstract][Full Text] [Related]
13. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer. Demirer T; Buckner CD; Appelbaum FR; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger WI Bone Marrow Transplant; 1996 May; 17(5):769-74. PubMed ID: 8733696 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous bone marrow support for breast cancer. Peters WP Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274 [No Abstract] [Full Text] [Related]
15. [Cancer of the breast: intensive treatment with bone marrow autografts]. Gisselbrecht C; Lepage E; Extra JM; Espie M; Andolenko P; Morvan F; Ganem G; Gerota Y; Bourstyn E; Marty M Bull Cancer; 1989; 76(1):99-104. PubMed ID: 2653474 [TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation in the treatment of breast cancer: clinical and technologic strategies. Vaughan WP Semin Oncol; 1993 Oct; 20(5 Suppl 6):55-8. PubMed ID: 8211216 [TBL] [Abstract][Full Text] [Related]
17. High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results. Baker WJ; Vukelja SJ; Burrell LM; Lee N; Perry JJ Bone Marrow Transplant; 1998 Apr; 21(8):775-8. PubMed ID: 9603400 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. Meisenberg BR; Ross M; Vredenburgh JJ; Jones R; Shpall EJ; Seigler HF; Coniglio DM; Wu K; Peters WP J Natl Cancer Inst; 1993 Jul; 85(13):1080-5. PubMed ID: 8515495 [TBL] [Abstract][Full Text] [Related]
19. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Merouani A; Shpall EJ; Jones RB; Archer PG; Schrier RW Kidney Int; 1996 Sep; 50(3):1026-31. PubMed ID: 8872980 [TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation for breast cancer. Peters WP Curr Opin Oncol; 1992 Apr; 4(2):279-82. PubMed ID: 1591302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]